close icon

Goldman Sachs to Find Elliott Wave Inspiration

A year ago, in March 2018, Goldman Sachs stock climbed to an all time high of over $275 per share. Unfortunately for the trend-followers, the rest of the year was nothing short of disastrous. GS dipped below $152 in December before closing the year at $167.05 for a total annual loss of 35.2%.

The stock finished at $188.96 last week after the bulls’ ambitions were rejected by the resistance near $206. Goldman Sachs is a financially strong and very profitable company, but that did not prevent the collapse in its stock price last year. Apparently, the fundamentals don’t tell the whole picture.

In order to find out what the recovery from $152 really means we need to examine its Elliott Wave structure. Take a look at it on the hourly chart below.

GS stock - Goldman Sachs Elliott Wave forecast

The sharp recovery from $151.70 to $203.29 can be seen as a five-wave impulse in wave (1/A), labeled 1-2-3-4-5. The Elliott Wave theory states that a three-wave correction in the opposite direction follows every impulse. In Goldman’s case, wave (2/B) looks like an A-B-C expanding flat retracement.

Waves A and B are simple a-b-c zigzags, while wave C is still in progress. If this count is correct, once wave C completes the 5-3 wave cycle the trend can be expected to resume in the direction of the impulsive sequence. Targets above $210 a share make sense in the mid-term, unless the price drops to a new low below $152.

In addition, traditional valuation ratios such as P/B and P/E also suggest Goldman Sachs is currently undervalued. When technical and fundamental methods both point in the same direction, it’s a risk worth taking.

Did you like this analysis? Our Elliott Wave Video Course can teach you how to uncover the patterns yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

Campari Bulls to Get a Serious Hangover Soon

Campari is an Italian liquor and spirits maker with traditions dating back to 1860. The company’s stock price plunged sharply in March along with the markets in general and then recovered just as quickly to new records by year-end. As shares hover near all-time highs, however, dark clouds appear to be gathering over the spirits…

Read More »

Experian to Drop 35% Before Uptrend Can Resume

Like most technology firms, Experian adapted to the new work-from-home environment relatively quickly. The Irish data and analytics company even managed to grow its revenue in 2020, even though its EPS didn’t change much from 2019. After the initial coronavirus selloff in March, the stock swiftly recovered, as well. EXPN.L is currently hovering around 2900…

Read More »

More analyses